INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Mar 27, 2023 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 3,609 |
Mar 27, 2023 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 569,653 |
Mar 27, 2023 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 5,869 |
Mar 27, 2023 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 200,000 |
Mar 27, 2023 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 250,000 |
Mar 28, 2023 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 10 | $818.81 | 32,919 |
Mar 28, 2023 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 115 | $820.85 | 32,804 |
Mar 28, 2023 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 142 | $821.40 | 32,662 |
Mar 28, 2023 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 128 | $822.67 | 32,534 |
Mar 28, 2023 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Open market or private sale of non-derivative or derivative security | 181 | $823.60 | 32,353 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.